Glenn Wagner

Biography

Glenn Wagner is a senior behavioral scientist at the RAND Corporation and a professor at the Pardee RAND Graduate School. He has been involved in clinical and behavioral HIV research for more than 20 years and has extensive experience with both HIV prevention and treatment research. For more than 10 years, Wagner has conducted several National Institutes of Health–funded research in the United States on HIV antiretroviral adherence, including methodological studies of adherence measurement and randomized, controlled studies of adherence interventions. Most recently, Wagner has led a group of RAND scientists in developing international HIV research in sub-Saharan Africa, Latin America, and the Middle East. In Uganda, his projects include a longitudinal evaluation of the social, economic, and risk behavior outcomes of HIV antiretroviral therapy (ART), evaluation of depression treatment as a moderator of ART impact, and a formative and process evaluation of microfinance programs targeting HIV clients. Future research studies based in sub-Saharan Africa will focus on fertility rights of HIV clients and improving reproductive health services. In Honduras, Wagner is working with Homero Martinez on evaluating nutritional interventions and their effects on HIV adherence and clinical outcomes. Finally, in Lebanon and Palestine, Wagner is working with colleagues at RAND to develop proposals regarding HIV prevention and risk reduction among men who have sex with men and among youth, respectively. Wagner received his Ph.D. in clinical psychology from St. John's University.